Ranbaxy Halts Raw Material Supplies From Toansa And Dewas Sites
This article was originally published in PharmAsia News
Executive Summary
Ranbaxy has said it will temporarily discontinue shipping raw materials from its manufacturing sites at Toansa and Dewas in India as part of a comprehensive reform. Experts believe the supplies may be halted for two to three months.